Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia.
El-Husseini
Randa
R
Division of Gastroenterology, New England Medical Center, Tufts University School of Medicine, 750 Washington Street, Boston, MA 02111, USA.
Kaplan
Marshall M
MM
D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications* / Q000175:diagnosis; D008105:Liver Cirrhosis, Biliary / Q000150:complications* / Q000175:diagnosis; D008111:Liver Function Tests; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D014580:Ursodeoxycholic Acid; D011433:Propranolol